U.S. markets open in 8 hours 42 minutes

Pharmadrug Inc. (LMLLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0890+0.0020 (+2.30%)
At close: 3:53PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0870
Open0.0890
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0700 - 0.1000
52 Week Range0.0021 - 0.1300
Volume407,862
Avg. Volume250,206
Market Cap14.334M
Beta (5Y Monthly)3.86
PE Ratio (TTM)N/A
EPS (TTM)-0.1490
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer
      Newsfile

      PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

      Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, today announced that it has entered into the definitive agreement in respect of the previously announced (see press release dated January 12, 2021) proposed acquisition of Sairiyo Therapeutics Inc. ("Sairiyo") on January 12, ...

    • CNW Group

      IIROC Trade Resumption - BUZZ

      VANCOUVER, BC, Jan. 12, 2021 /CNW/ - Trading resumes in:Company: Pharmadrug Inc.

    • PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.
      Newsfile

      PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.

      Toronto, Ontario--(Newsfile Corp. - January 12, 2021) -  PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that it has entered into a binding letter of intent (the "LOI"), dated January 11, 2021, to acquire Sairiyo Therapeutics Inc. ("Sairiyo") (the "Acquisition"). Sairiyo is a biotechnology ...